dc.contributor.author |
Crosby, E. |
|
dc.contributor.author |
Llosa, L. |
|
dc.contributor.author |
Quesada, M.M. |
|
dc.contributor.author |
Carrillo, P.C. |
|
dc.contributor.author |
Gotuzzo Herencia, José Eduardo |
|
dc.date.accessioned |
2022-10-09T23:25:32Z |
|
dc.date.available |
2022-10-09T23:25:32Z |
|
dc.date.issued |
1984 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/12312 |
|
dc.description.abstract |
Hematologic abnormalities were studied prospectively in 38 patients with brucellosis. Anemia was found in 74% of patients, leukopenia in 45%, neutropenia in 21%, lymphopenia in 63% and thrombocytopenia in 39.5%. Eight patients (21%) were pancytopenic|; seven of these individuals also had splenomegaly. Bone marrow hypoplasia was not found. Bleeding complications developed in 26% of patients and were significantly associated with clotting abnormalities (low platelet count, low fibrinogen level, and/or prolongation of thrombin clotting time); i.e., bleeding occurred in ~50% of patients with marked clotting abnormalities but in no patients with normal clotting. Determination of fibrinogen levels at different stages of brucellosis led to a redefinition of the normal level for patients with this infection. Patients without clotting abnormalities had fibrinogen levels of 233-711 mg/100 ml (mean, 384 mg/100 ml), whereas patients with thrombocytopenia and prolonged thrombin clotting time had levels of 122-360 mg/100 ml (mean, 216 mg/100 ml; P < .001) that increased to 233-519 mg/100 (mean, 360 mg/100 ml) when clotting values returned to normal. Lymphopenia was significantly correlated with the severity of clinical manifestations (bleeding and hepatic involvement). |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Oxford University Press |
|
dc.relation.ispartofseries |
Journal of Infectious Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
anemia |
en_US |
dc.subject |
hemorrhage |
en_US |
dc.subject |
brucellosis |
en_US |
dc.subject |
neutropenia |
en_US |
dc.subject |
blood coagulation |
en_US |
dc.subject |
leukopenia |
en_US |
dc.subject |
lymphopenia |
en_US |
dc.subject |
splenomegaly |
en_US |
dc.subject |
thrombin time |
en_US |
dc.subject |
thrombocytopenia |
en_US |
dc.subject |
infectionsfibrinogen assay |
en_US |
dc.subject |
hematology |
en_US |
dc.subject |
abnormal hematology findings |
en_US |
dc.subject |
coagulation process |
en_US |
dc.subject |
bone marrow |
en_US |
dc.subject |
hypocellular |
en_US |
dc.title |
Hematologic changes in brucellosis |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1093/infdis/150.3.419 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.08 |
|
dc.relation.issn |
1537-6613 |
|